{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-023797","form_type":"8-K","ticker":"FZMD","cik":"0000319016","company_name":"Fuse Medical, Inc.","filed_at":"2023-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.249676+00:00","generated_at":"2026-06-11T09:44:29.351256+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Fuse Medical Q2 2023 net income $307,588 vs loss of $322,936 a year ago","bullets":["Revenue rose 7% to $5.0M from $4.7M in Q2 2022.","Gross profit grew 31% to $3.5M (69% margin) from $2.6M (57% margin).","SG&A expense increased to $1.6M from $1.4M; commissions down slightly.","EBITDA swung to $401,574 from a loss of $246,834 year-over-year.","CEO cites growth from portfolio of Fuse branded/manufactured products and national distribution expansion."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-023797","json":"https://secwatch.observer/filing/0001437749-23-023797.json","markdown":"https://secwatch.observer/filing/0001437749-23-023797.md","text":"https://secwatch.observer/filing/0001437749-23-023797.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/319016/000143774923023797/0001437749-23-023797-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/319016/000143774923023797/fzmd20230808c_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T09:44:29.351256+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"40758f55077549174ba4f1892b7f318471406e6c","claim":"Fuse Medical, Inc. reported second quarter ending June 30, 2023 results: revenue $5.0 million, net income $307,588.","evidence_excerpt":"quarter ended June 30, 2023 with the Securities and Exchange Commission (“SEC”). Second Quarter 2023 Financial Highlights ● Net revenues for the quarter ended June 30, 2023 were $5.0 million, compared to $4.7 million for the quarter ended June 30, 2022 which was an increase of approximately 7%. ● For the quarter ended June 30, 2023, gross profit was $3.5 million, or","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/319016/000143774923023797/0001437749-23-023797-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ending June 30, 2023"},{"label":"Revenue","value":"$5.0 million"},{"label":"Net income","value":"$307,588"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}